a close up shows a researcher working at a lab bench
24 January 2020

The University of Queensland has been asked to develop a vaccine for the recent coronavirus outbreak at unprecedented speed, using new technology.

The Coalition for Epidemic Preparedness Innovations (CEPI) has requested the University use its recently developed rapid response technology to develop a new vaccine, which could be available worldwide in as little as six months.

UQ Vice-Chancellor and President Professor Peter H?j AC said the fluidity of the current outbreak represented a significant challenge to the international community.

“There is a lot that is still unknown regarding how easily the virus is able to be transmitted between humans,” he said.

“Working with CEPI, The University of Queensland is using its vaccine technology to respond to this global health challenge.”

Head of University's School of Chemistry and Molecular Biosciences, Professor Paul Young said The University of Queensland had novel technology for the rapid generation of new vaccines from the knowledge of a virus’s genetic sequence information.

“The team hopes to develop a vaccine over the next six months, which may be used to help contain this outbreak,” he said.

“The vaccine would be distributed to first responders, helping to contain the virus from spreading around the world.”

Dr Keith Chappell describes the Vaccine Pipeline from The University of Queensland in 2019.

Dr Keith Chappell, from UQ’s School of Chemistry and Molecular Biosciences and the Australian Institute for Bioengineering and Nanotechnology said the key to the speedy development of this potential vaccine was the 'molecular clamp' technology, invented by UQ scientists and patented by UniQuest.

"The University of Queensland's molecular clamp technology provides stability to the viral protein that is the primary target for our immune defence," he said.

“The technology has been designed as a platform approach to generate vaccines against a range of human and animal viruses and has shown promising results in the laboratory targeting viruses such as influenza, Ebola, Nipah and MERS coronavirus.”

Images, captions, the full press conference and other video available via Dropbox.

Media: UQ communication, [email protected], +61 73365 1120; Tom Matthews, [email protected], +61 468 746 070.


ag软件挂机打公式自动投注 信富配资 今日新浪体育新闻 中国最好的配资公司 皇冠足球指数全讯网 福建22选5 科创股票涨跌幅限制 火牛网配资 福建十一选五 顺发配资 融盛在线配资 喜乐彩 点点盈配资 竞彩足球即时指数 黑龙江36选7 易资配 高升网